Search all trials

Find therapies in clinical trials near you

Search by disease and location to discover available clinical trials matching your criteria. Updated every day from authoritative EU registries.

recruiting: 3 961
countries: 28
conditions: 2 103

3 961 trials recruiting28 European countries2 103 conditions coveredUpdated today

Quick filters

Dilated cardiomyopathy

Recruiting

Investigational

A Study of Danicamtiv for Adults with Symptomatic Genetic and Familial Dilated Cardiomyopathy to Test if it Improves Heart Function and Exercise Ability

Investigational

Belgium

Participants:18–64 years · 65+ years
Substances:Danicamtiv

Contact Research Centre

Dilated cardiomyopathy+1

Recruiting

Registered drugNo placebo

Study on Early Use of Ivabradine for Children with Heart Failure Due to Dilated Cardiomyopathy

Registered drugNo placebo

Italy

Participants:0–17 years
Substances:Ivabradine Hydrochloride

Contact Research Centre

Dilated cardiomyopathy

Recruiting

Registered drugNo placebo

Study of Risedronate Sodium for Patients with Dilated Cardiomyopathy Due to Troponin T Gene Mutation

Registered drugNo placebo

Spain

Participants:18–64 years · 65+ years
Substances:Risedronate Sodium

Contact Research Centre

Dilated cardiomyopathy+1

Recruiting

Registered drug

Study on Early Use of Candesartan vs Placebo for People with Genetic Risk of Dilated Cardiomyopathy

Registered drug

The Netherlands

Participants:18–64 years
Substances:Candesartan Cilexetil

Contact Research Centre

Dilated cardiomyopathy

Recruiting

Registered drugNo placebo

Study on Anakinra for Treating Inflammatory Dilated Cardiomyopathy in Patients: Evaluating Efficacy and Safety of Anakinra with Standard Care vs. Standard Care Alone

Registered drugNo placebo

Italy

Participants:18–64 years · 65+ years
Substances:Anakinra

Contact Research Centre

Dilated cardiomyopathy

Not yet recruiting

InvestigationalNo placebo

Long‑Term Safety and Efficacy Study of Danicamtiv in Adults with Symptomatic Genetic and Familial Dilated Cardiomyopathy

InvestigationalNo placebo

Belgium

Participants:18–64 years · 65+ years
Substances:Danicamtiv

Contact Research Centre

Dilated cardiomyopathy

Not recruiting

Investigational

Study of AB-1002 gene therapy given through coronary arteries in adults with severe (NYHA Class III) heart failure caused by non-ischemic cardiomyopathy

Investigational

Austria

Participants:18–64 years · 65+ years
Substances:Ab-1002

Contact Research Centre

Dilated cardiomyopathy+1

Not recruiting

Investigational

Study on the Effectiveness of Autologous Bone Marrow Cells for Patients with Dilated Cardiomyopathy and Heart Failure

Investigational

Spain

Participants:18–64 years · 65+ years
Substances:Autologous Bone Marrow-Derived Adult Mononuclear Cells, Not Expanded

Contact Research Centre

Dilated cardiomyopathy

Not recruiting

InvestigationalNo placebo

Study on Danicamtiv for Patients with Primary Dilated Cardiomyopathy Due to MYH7 or TTN Gene Variants

InvestigationalNo placebo

Germany

Participants:18–64 years · 65+ years
Substances:Danicamtiv

Contact Research Centre

Find therapies in clinical trials near you

9 trials match your criteria

Dilated cardiomyopathy

A Study of Danicamtiv for Adults with Symptomatic Genetic and Familial Dilated Cardiomyopathy to Test if it Improves Heart Function and Exercise Ability

Dilated cardiomyopathy+1

Study on Early Use of Ivabradine for Children with Heart Failure Due to Dilated Cardiomyopathy

Dilated cardiomyopathy

Study of Risedronate Sodium for Patients with Dilated Cardiomyopathy Due to Troponin T Gene Mutation

Dilated cardiomyopathy+1

Study on Early Use of Candesartan vs Placebo for People with Genetic Risk of Dilated Cardiomyopathy

Dilated cardiomyopathy

Study on Anakinra for Treating Inflammatory Dilated Cardiomyopathy in Patients: Evaluating Efficacy and Safety of Anakinra with Standard Care vs. Standard Care Alone

Dilated cardiomyopathy

Long‑Term Safety and Efficacy Study of Danicamtiv in Adults with Symptomatic Genetic and Familial Dilated Cardiomyopathy

Dilated cardiomyopathy

Study of AB-1002 gene therapy given through coronary arteries in adults with severe (NYHA Class III) heart failure caused by non-ischemic cardiomyopathy

Dilated cardiomyopathy+1

Study on the Effectiveness of Autologous Bone Marrow Cells for Patients with Dilated Cardiomyopathy and Heart Failure

Dilated cardiomyopathy

Study on Danicamtiv for Patients with Primary Dilated Cardiomyopathy Due to MYH7 or TTN Gene Variants

Explore other searches

Vaccine trials

Paediatric trials · ages 0–17

Healthy volunteers

Helpful resources

How applying through us works

What happens after you apply

Guides for patients and volunteers

Search filters

Prefer not to search? Our Concierge searches the trials for you.